Sao Paulo Medical School
Professor Gerson Chadi, MD. PHD., is Full Professor at the Department of Neurology of the University of Sao Paulo Medical School (USP), Brazil, since 1998. He specialized in Neurodegenerative Diseases and Advanced Research on Regeneration of Central Nervous System in the periods he developed a Post-doctoral fellow at the Karolinska Institute, Sweden (1991-1994), and also a senior sabbatical at the Clarke Institute of Psychiatry of the University of Toronto and at the Montreal Neurological Institute of the McGill University (1999). He introduced in Brazil the concepts and research methods in the Central Nervous System Regeneration (1994) and was one of the signatories of the Beijing Letter which created the Neurorestauratology Discipline in the field of Neurology. He heads the Translational Neurology Unit, the Translational Neurology Laboratory and the Neuroregeneration Research Center at Department of Neurology of USP. He coordinates the Neurological Genomic Project and the Cell Therapy Project of his Medical School. He joined the Advisory Board of the "Center for Research and Neuroscience and Behavior of USP", in the area of Neuroplasticity and Development for 10 years. He introduced the first Brazilian Systematic Translational Research on Amyotrophic Lateral Sclerosis (ALS, bench to bed, side 2010), being responsible for various clinical and laboratory projects on ALS research. Ongoing projects employ advanced methodology in molecular / cellular biology, large gene profiling, expanded gene sequencing, stem cell transformation, biomarkers and bioinformatics. He published more than 100 scientific peer reviewed papers in International Scientific Journals, graduated over than 60 Master, PhD and post doctoral students.
Neuronal plasticity, regeneration of the nervous system, biomedical Informatics, translational neurology, therapeutic targets, mutational analyses, biomarkers, cell therapy, neurorehabilitation, healthcare, clinical trials in the fields of neurotrauma and neurodegenerative diseases with focus on Amyotrophic Lateral Sclerosis.